Catalytic synthesis of 9-cis-retinoids: mechanistic insights.


Journal

Dalton transactions (Cambridge, England : 2003)
ISSN: 1477-9234
Titre abrégé: Dalton Trans
Pays: England
ID NLM: 101176026

Informations de publication

Date de publication:
16 Jul 2019
Historique:
pubmed: 21 6 2019
medline: 21 6 2019
entrez: 21 6 2019
Statut: ppublish

Résumé

The regioselective Z-isomerization of thermodynamically stable all-trans retinoids remains challenging, and ultimately limits the availability of much needed therapeutics for the treatment of human diseases. We present here a novel, straightforward approach for the catalytic Z-isomerization of retinoids using conventional heat treatment or microwave irradiation. A screen of 20 transition metal-based catalysts identified an optimal approach for the regioselective production of Z-retinoids. The most effective catalytic system was comprised of a palladium complex with labile ligands. Several mechanistic studies, including isotopic H/D exchange and state-of-the-art quantum chemical calculations using coupled cluster methods indicate that the isomerization is initiated by catalyst dimerization followed by the formation of a cyclic, six-membered chloropalladate catalyst-substrate adduct, which eventually opens to produce the desired Z-isomer. The synthetic development described here, combined with thorough mechanistic analysis of the underlying chemistry, highlights the use of readily available transition metal-based catalysts in straightforward formats for gram-scale drug synthesis.

Identifiants

pubmed: 31218312
doi: 10.1039/c9dt02189b
pmc: PMC7004310
mid: NIHMS1551403
doi:

Types de publication

Journal Article

Langues

eng

Pagination

10581-10595

Subventions

Organisme : NEI NIH HHS
ID : R01 EY009339
Pays : United States
Organisme : NEI NIH HHS
ID : R24 EY027283
Pays : United States

Références

Chem Soc Rev. 2008 Jun;37(6):1127-39
pubmed: 18497926
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8623-8
pubmed: 10869443
Nutrients. 2011 Apr;3(4):385-428
pubmed: 22254103
Adv Exp Med Biol. 1994;352:187-200
pubmed: 7832047
N Engl J Med. 1986 Dec 11;315(24):1501-5
pubmed: 3537787
J Comput Chem. 2011 May;32(7):1456-65
pubmed: 21370243
J Chem Theory Comput. 2016 Apr 12;12(4):1542-60
pubmed: 27002380
J Chem Phys. 2011 Oct 14;135(14):144105
pubmed: 22010696
Biochim Biophys Acta. 2012 Jan;1821(1):137-51
pubmed: 21447403
Br J Pharmacol. 2018 Dec;175(23):4285-4294
pubmed: 30298911
J Phys Chem B. 2005 Sep 15;109(36):17232-8
pubmed: 16853199
Nat Rev Cancer. 2001 Dec;1(3):181-93
pubmed: 11902573
Nutrients. 2017 Feb 20;9(2):
pubmed: 28230720
Angew Chem Int Ed Engl. 2012 Jan 27;51(5):1270-3
pubmed: 22173992
J Phys Chem A. 2017 Jun 8;121(22):4379-4387
pubmed: 28514153
Lancet. 1980 Nov 15;2(8203):1048-9
pubmed: 6107678
Phys Rev B Condens Matter. 1986 Jun 15;33(12):8822-8824
pubmed: 9938299
Phys Chem Chem Phys. 2006 May 7;8(17):1985-93
pubmed: 16633685
J Chem Phys. 2010 Apr 21;132(15):154104
pubmed: 20423165
Prog Retin Eye Res. 2015 Nov;49:46-66
pubmed: 26187035
Acc Chem Res. 2002 Sep;35(9):717-27
pubmed: 12234201
Phys Chem Chem Phys. 2008 Oct 28;10(40):6144-9
pubmed: 18846304
Mol Pharmacol. 2018 May;93(5):438-452
pubmed: 29453250
Annu Rev Phys Chem. 2012;63:45-64
pubmed: 22404585
Hum Mol Genet. 2009 Jun 15;18(12):2277-87
pubmed: 19339306
J Chem Phys. 2013 Oct 7;139(13):134101
pubmed: 24116546
Angew Chem Int Ed Engl. 2011 Oct 4;50(41):9602-6
pubmed: 21938759
Wiad Lek. 2001;54 Suppl 1:301-6
pubmed: 12182039
Curr Cancer Drug Targets. 2004 May;4(3):285-98
pubmed: 15134535
J Phys Chem Lett. 2016 Oct 20;7(20):4207-4212
pubmed: 27690453
Phys Rev A Gen Phys. 1988 Sep 15;38(6):3098-3100
pubmed: 9900728
Chem Rev. 2012 Jan 11;112(1):385-402
pubmed: 21678899
J Comput Chem. 2007 Jan 15;28(1):204-21
pubmed: 17066501
Vision Res. 1984;24(8):783-7
pubmed: 6474835
Phys Chem Chem Phys. 2005 Sep 21;7(18):3297-305
pubmed: 16240044
Arch Ophthalmol. 2010 Nov;128(11):1442-8
pubmed: 20837787
J Chem Theory Comput. 2015 Oct 13;11(10):4664-76
pubmed: 26574257
Sci Rep. 2018 Apr 17;8(1):6130
pubmed: 29666392
Magn Reson Chem. 2013 Jul;51(7):435-8
pubmed: 23630063
J Biol Chem. 2012 Jan 13;287(3):1612-9
pubmed: 22074921
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4368-78
pubmed: 19407008

Auteurs

Shirin Kahremany (S)

Gavin Herbert Eye Institute, Department of Ophthalmology, University of California, Irvine, CA 92697, USA. kpalczew@uci.edu skahrema@uci.edu and Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA.

Adam Kubas (A)

Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland. akubas@ichf.edu.pl.

Gregory P Tochtrop (GP)

Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA.

Krzysztof Palczewski (K)

Gavin Herbert Eye Institute, Department of Ophthalmology, University of California, Irvine, CA 92697, USA. kpalczew@uci.edu skahrema@uci.edu and Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA.

Classifications MeSH